Skip to main content

Broadwood Partners, L.P.'s Form 4 filing

Insight Molecular Diagnostics Inc. (IMDX) · filed Apr 15, 2024

Accession no.
0000919574-24-002558
Filed
Apr 15, 2024, 7:21 PM ET
Trade date
Apr 11-15, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $7.06M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Broadwood Partners, L.P.CIK 000127838610% Owner
Broadwood Capital IncCIK 000127838710% Owner
Bradsher Neal CCIK 000127838810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 11, 2024Common Stock, no par valuePPurchaseAcquired+2,420,000$2.92+$7,057,6884,929,066Direct
Apr 11, 2024Common Stock, no par valuePPurchaseAcquired0$0.00$04,929,066Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 15, 2024Common StockJOtherDisposed−107,488––0Direct
Apr 15, 2024Common StockJOtherDisposed−107,488––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)